Therefore, we used patient samples and cell lines of pancreatic cancer to examine whether SPOP activity may be associated with the onset or progression of this disease and, if so, whether SPOP exerts its effects through its role in promoting the ubiquitination-dependent degradation of NANOG. This evidence concerns the gene NANOG and pancreatic neoplasm.